Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evaluation of the first small-molecule inhibitors
2023/51/B/NZ7/03056
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ3_01: Biologia komórki
- ST4_03: Struktura i architektura molekularna
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy
Voivodeship: kujawsko-pomorskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 8
Call
OPUS 26 – announced on 2023-09-18
- Amount awarded
- 1 564 317 PLN
- Project start date
- 2024-07-24
- Project end date
- 2027-07-23
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.